Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency

JAMA

Volumn 310, Issue 22, 2013, Pages 2435-2442

  Lam, Jameson R ^a   Schneider, Jennifer L ^a   Zhao, Wei ^a   Corley, Douglas A ^a  

^a DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; TREATMENT DURATION; UNITED STATES; VERY ELDERLY; HEALTH MAINTENANCE ORGANIZATION; RISK; STATISTICS AND NUMERICAL DATA; VITAMIN B 12 DEFICIENCY;

ADULT; AGED; AGED, 80 AND OVER; CALIFORNIA; CASE-CONTROL STUDIES; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PROTON PUMP INHIBITORS; RISK; VITAMIN B 12 DEFICIENCY;

EID: 84889821934     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.280490     Document Type: Article

References (33)

1. Evatt MLMP, Bobo JK, Kimmons J, Williams J. Why Vitamin B12 Deficiency Should Be on Your Radar Screen. Centers for Disease Control and Prevention website. http://www.cdc.gov/ncbddd/b12/index.html. Accessed July 18, 2012.
2. Lindenbaum J, Rosenberg IH, Wilson PW, et al. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr. 1994;60(1):2-11.
3. Pennypacker LC, Allen RH, Kelly JP, et al. High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc. 1992;40(12):1197-1204.
4. Declining Medicine Use and Costs: For Better or Worse? A Review of the Use of Medicines in the United States in 2012. IMS Health website. http://www.imshealth.com/deployedfiles/ims/Global/Content/Insights/ IMS%20Institute%20for%20Healthcare%20Informatics/2012%20U.S. %20Medicines%20Report/2012-U.S.Medicines-Report.pdf. 2013.
5. Toh BH, van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med. 1997;337(20):1441-1448.
6. 12 levels in patients with Zollinger-Ellison syndrome. Am J Med. 1998;104(5):422-430.
7. 12 deficiency in older adults. J Clin Epidemiol. 2004;57(4):422-428.
8. 12 status in older adults? J Am Med Dir Assoc. 2008;9(3):162-167.
9. 12). Ann Intern Med. 1994;120(3):211-215.
10. 12 during prolonged omeprazole therapy. J Clin Gastroenterol. 1992;14(4):288-292.
11. Schenk BE, Festen HP, Kuipers EJ, Klinkenberg-Knol EC, Meuwissen SG. Effect of short- and long-term treatment with omeprazole on the absorption and serum levels of cobalamin. Aliment Pharmacol Ther. 1996;10(4):541-545.
12. 12 status in elderly individuals. Aliment Pharmacol Ther. 2008;27(6):491-497.
13. ter Heide H, Hendriks HJ, Heijmans H, et al. Are children with cystic fibrosis who are treated with a proton-pump inhibitor at risk for vitamin B(12) deficiency? J Pediatr Gastroenterol Nutr. 2001;33(3):342-345.
14. Tolia V, Boyer K. Long-term proton pump inhibitor use in children: a retrospective review of safety. Dig Dis Sci. 2008;53(2):385-393.
15. 12 deficiency in hypersecretors during long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther. 2008;27(11):1110-1121.
16. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82(5):703-710.
17. Graham DJ, Campen D, Hui R, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs. Lancet. 2005;365(9458):475-481.
18. Schatz M, Zeiger RS, Vollmer WM, et al. Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data. J Allergy Clin Immunol. 2006;117(5):995-1000.
19. Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med. 1988;318(26):1720-1728.
20. Pflipsen MC, Oh RC, Saguil A, et al. The prevalence of vitamin B(12) deficiency in patients with type 2 diabetes [published correction appears in J Am Board Fam Med. 2010;23(5):695]. J Am Board Fam Med. 2009;22(5):528-534.
21. 12 deficiency common in primary hypothyroidism [published correction appears in J Pak Med Assoc. 2009;59(2):126]. J Pak Med Assoc. 2008;58(5):258-261.
22. 12 deficiency? Arch Intern Med. 2000;160(9):1349-1353.
23. Stabler SP, Lindenbaum J, Allen RH. Vitamin B-12 deficiency in the elderly: current dilemmas. Am J Clin Nutr. 1997;66(4):741-749.
24. 12, thiocyanate, and folate levels in the blood of normal subjects. Br Med J. 1972;3(5821):260-263.
25. Laufer EM, Hartman TJ, Baer DJ, et al. Effects of moderate alcohol consumption on folate and vitamin B(12) status in postmenopausal women. Eur J Clin Nutr. 2004;58(11):1518-1524.
26. Ting RZ, Szeto CC, Chan MH, Ma KK, Chow KM. Risk factors of vitamin B(12) deficiency in patients receiving metformin. Arch Intern Med. 2006;166(18):1975-1979.
27. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008.
28. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York, NY: Wiley; 2000.
29. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research : Principles and Quantitative Methods. Belmont, CA: Lifetime Learning Publications; 1982.
30. Breslow NE, Day NE. Statistical methods in cancer research: volume I - the analysis of case-control studies. IARC Sci Publ. 1980;(32):5-338.
31. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295-300.
32. 12 deficiency in patients with autoimmune thyroid disease. Am J Med Sci. 2006;332(3):119-122.
33. 12 absorption. J Am Coll Nutr. 1994;13(6):584-591.